Shawn Cross

Companies

• Pacira BioSciences, Inc.Chief financial officer Oct 23, 2024 to now¹
• Cyclo Therapeutics, Inc.Board member Dec 28, 2023 to Mar 3, 2025²
• Applied Molecular Transport Inc.Chief executive officer Mar 27, 2023 to Dec 28, 2023³
• Applied Molecular Transport Inc.Chair Mar 27, 2023 to Dec 28, 2023³
• Applied Molecular Transport Inc.Chief operating officer May 18, 2022 to Mar 3, 2023⁴
• Applied Molecular Transport Inc.President May 18, 2022 to Mar 3, 2023⁴
• Applied Molecular Transport Inc.Chief financial officer Jun 4, 2020 to Feb 16, 2022⁵
• BioPlus Acquisition Corp.Board member Dec 2, 2021 to Dec 2, 2021⁶
• GT Biopharma, Inc.Board member Mar 16, 2018 to Mar 16, 2018⁷
• GT Biopharma, Inc.Chief executive officer Mar 16, 2018 to Mar 16, 2018⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PBPacira BioSciences, Inc. PCRX105,341 shares⁸$3.8M at $36.33Apr 23, 2026
• CTCyclo Therapeutics, Inc.136,346 shares⁹Feb 27, 2025
• AMApplied Molecular Transport Inc.0 shares¹⁰Dec 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 23, 2026Sold 12,941 shares at $25.16 of Pacira BioSciences, Inc.⁸
• Apr 23, 2026Exercised options 12,941 shares at $16.45 of Pacira BioSciences, Inc.⁸
• Apr 22, 2026Sold 1,500 shares at $25.01 of Pacira BioSciences, Inc.¹¹
• Apr 22, 2026Exercised options 1,500 shares at $16.45 of Pacira BioSciences, Inc.¹¹
• Apr 21, 2026Sold 2,845 shares at $25.01 of Pacira BioSciences, Inc.¹¹
• Apr 21, 2026Exercised options 2,845 shares at $16.45 of Pacira BioSciences, Inc.¹¹
• Apr 20, 2026Sold 7,714 shares at $25.14 of Pacira BioSciences, Inc.¹¹
• Apr 20, 2026Exercised options 7,714 shares at $16.45 of Pacira BioSciences, Inc.¹¹
• Feb 11, 2026Granted 49,091 shares of Pacira BioSciences, Inc.¹²
• Dec 10, 2025Sold 9,104 shares at $25.14 of Pacira BioSciences, Inc.¹³
• Dec 10, 2025Exercised options 9,104 shares at $16.45 of Pacira BioSciences, Inc.¹³
• Dec 9, 2025Sold 15,896 shares at $25.03 of Pacira BioSciences, Inc.¹³
• Dec 9, 2025Exercised options 15,896 shares at $16.45 of Pacira BioSciences, Inc.¹³
• Nov 10, 2025Sold 12,060 shares at $22.09 of Pacira BioSciences, Inc.¹⁴
• Oct 31, 2025Shares withheld for tax 6,690 shares at $21.38 of Pacira BioSciences, Inc.¹⁵
• Feb 27, 2025Granted 28,597 shares of Cyclo Therapeutics, Inc.⁹
• Nov 15, 2024Granted 17,228 shares of Cyclo Therapeutics, Inc.¹⁶
• Nov 1, 2024Granted 75,000 shares of Pacira BioSciences, Inc.¹⁷
• Aug 16, 2024Granted 9,028 shares of Cyclo Therapeutics, Inc.¹⁸
• Jun 3, 2024Granted 8,887 shares of Cyclo Therapeutics, Inc.¹⁹
• Dec 27, 2023Granted 72,606 shares of Cyclo Therapeutics, Inc.²⁰
• Dec 27, 2023Returned to company 545,499 shares of Applied Molecular Transport Inc.¹⁰
• Nov 22, 2023Sold 110,802 shares at $0.16 of Applied Molecular Transport Inc.²¹
• Nov 15, 2023Sold 90,447 shares at $0.16 of Applied Molecular Transport Inc.²²
• Sep 29, 2023Sold 193,960 shares at $0.16 of Applied Molecular Transport Inc.²³